Found: 8
Select item for more details and to access through your institution.
A landscape of response to drug combinations in non-small cell lung cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39528-9
- By:
- Publication type:
- Article
Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin.
- Published in:
- PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0201046
- By:
- Publication type:
- Article
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 441, p. 1, doi. 10.1126/scitranslmed.aao4680
- By:
- Publication type:
- Article
BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.
- Published in:
- PLoS Biology, 2018, v. 16, n. 8, p. 1, doi. 10.1371/journal.pbio.2005756
- By:
- Publication type:
- Article
Systematic identification of genomic markers of drug sensitivity in cancer cells.
- Published in:
- Nature, 2012, v. 483, n. 7391, p. 570, doi. 10.1038/nature11005
- By:
- Publication type:
- Article
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
- Published in:
- Nucleic Acids Research, 2013, v. 41, p. D955, doi. 10.1093/nar/gks1111
- By:
- Publication type:
- Article
Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 10, p. 983, doi. 10.1038/nbt.3955
- By:
- Publication type:
- Article
Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy.
- Published in:
- Molecular Systems Biology, 2019, v. 15, n. 3, p. N.PAG, doi. 10.15252/msb.20188323
- By:
- Publication type:
- Article